Cardiogenic shock is usually associated with an extensive damage of the left ventricle connected with myocardial infarction. Frequency of cardiogenic shock in MI ranges from 5% to 10%, but it can also occur as a complication of right ventricular infarction (3% of cases). There are, however, other causes of the shock: valvular dysfunction (12%) or impaired blood flow in e.g. cardiac tamponade. Read full text »
In February 2012 in “The Lancet” a research team led by Maciej Tomaszewski published a work which describes a new risk factor for The Ischemic Heart Disease. The factor is located in the genetic code of the Y chromosome and is likely to be inherited. Read full text »
Scientists are working on developing a tagged antibody, which will identify atherosclerotic plaque and fat in the walls of arteries. Deposits are threatening with wall rupture and thrombus, so as a consequence with heart attack or ischemic brain stroke. The results of studies on the antibody were published in Circulation Research, journal of the American Heart Association (AHA). Read full text »
Cardiology – one of the fastest developing specializations, again takes a major step forward. After percutaneous interventions of stenting, valve replacements, atrial septal defect occlusion, atrial appendage occlusion, time has come for even greater interference in human heart’s structure. Now the scientists get closer to the total replacement of insufficient ventricles with artificial heart. Although, the mankind has dreamt of placing a machine inside the chest for generations, the mechanism of similar size, weight, and functioning as a human heart has not been created until now. The task has been accomplished by a French research group that developed a prototype named CARMAT. This artificial heart model has been recently launched into the first phase of clinical testing and this year it is to be implanted into several patients. Read full text »
Written for Physician’s Weekly.
A new blood test may predict patients at risk of an imminent heart attack. Researchers have discovered mutated circulating endothelial cells (CECs) that are released into the bloodstream days before the formation of a clot. A blood test may be used to identify this particular cell type up to 2 weeks before the heart attack is likely to occur. Continue reading